Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fleming

Showing results (721-730 of 739) with videos related to

Pageof 74
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1)Kevin J Wilson, David J Witter, Jonathan B Grimm, et al.
Frontiers in Physiology|July 11, 2022
eNAMPT Neutralization Preserves Lung Fluid Balance and Reduces Acute Renal Injury in Porcine Sepsis/VILI-Induced Inflammatory Lung InjurySaad Sammani, Tadeo Bermudez, Carrie L Kempf, et al.
The American Journal of Sports Medicine|January 16, 2023
Quantitative MRI Biomarkers to Predict Risk of Reinjury Within 2 Years After Bridge-Enhanced ACL RestorationDominique A Barnes, Gary J Badger, Yi-Meng Yen, et al.
The American Journal of Sports Medicine|November 22, 2022
Preoperative Risk Factors for Subsequent Ipsilateral ACL Revision Surgery After an ACL Restoration ProcedureRyan M Sanborn, Gary J Badger, Braden C Fleming, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Christopher L Hamblett, Dawn M Mampreian, et al.
The New England Journal of Medicine|May 4, 2017
Teprotumumab for Thyroid-Associated OphthalmopathyTerry J Smith, George J Kahaly, Daniel G Ezra, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 7, 2025
Nodal status in major salivary gland cancer: External validation of a novel N- classificationDavide Lombardi, Michele Tomasoni, Francesco Missale, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimizationSolomon D Kattar, Laura M Surdi, Anna Zabierek, et al.
Orthopaedic Journal of Sports Medicine|January 31, 2022
Design Features and Rationale of the BEAR-MOON (Bridge-Enhanced ACL Restoration Multicenter Orthopaedic Outcomes Network) Randomized Clinical Trial, Kurt P Spindler, Peter B Imrey, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 74

Showing results (721-730 of 739) with videos related to

Sort By:
Pageof 74
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1)Kevin J Wilson, David J Witter, Jonathan B Grimm, et al.
Frontiers in Physiology|July 11, 2022
eNAMPT Neutralization Preserves Lung Fluid Balance and Reduces Acute Renal Injury in Porcine Sepsis/VILI-Induced Inflammatory Lung InjurySaad Sammani, Tadeo Bermudez, Carrie L Kempf, et al.
The American Journal of Sports Medicine|January 16, 2023
Quantitative MRI Biomarkers to Predict Risk of Reinjury Within 2 Years After Bridge-Enhanced ACL RestorationDominique A Barnes, Gary J Badger, Yi-Meng Yen, et al.
The American Journal of Sports Medicine|November 22, 2022
Preoperative Risk Factors for Subsequent Ipsilateral ACL Revision Surgery After an ACL Restoration ProcedureRyan M Sanborn, Gary J Badger, Braden C Fleming, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Christopher L Hamblett, Dawn M Mampreian, et al.
The New England Journal of Medicine|May 4, 2017
Teprotumumab for Thyroid-Associated OphthalmopathyTerry J Smith, George J Kahaly, Daniel G Ezra, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 7, 2025
Nodal status in major salivary gland cancer: External validation of a novel N- classificationDavide Lombardi, Michele Tomasoni, Francesco Missale, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimizationSolomon D Kattar, Laura M Surdi, Anna Zabierek, et al.
Orthopaedic Journal of Sports Medicine|January 31, 2022
Design Features and Rationale of the BEAR-MOON (Bridge-Enhanced ACL Restoration Multicenter Orthopaedic Outcomes Network) Randomized Clinical Trial, Kurt P Spindler, Peter B Imrey, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 74